Skip to main content

Table 7 Primary method of medicinal cannabis use among various pain syndromes, “Yes” responses on ID Migraine™ questionnaire, top non-pain related primary illnesses, and overall cohort

From: Patterns of medicinal cannabis use, strain analysis, and substitution effect among patients with migraine, headache, arthritis, and chronic pain in a medicinal cannabis cohort

Primary method of use
  Vaporizer Pipe Joint Oral/ Edible Waterpipe/ Bong Juicing Tea Topical
Headache as primary symptom (505) 162 (32.1%) 50 (9.9%) 170 (33.7%) 58 (11.5%) 63 (12.5%) 1 (0.2%) 1 (0.2%)  
Headache as primary illness (75) 26 (34.7%) 8 (10.7%) 22 (29.3%) 9 (12%) 8 (10.7%) 1 (1.3%) 1 (1.3%)  
Chronic pain as primary illness (598) 179 (29.9%) 56 (9.4%) 183 (30.6%) 120 (20.1%) 56 (9.4%) 1 (0.17%)   3 (0.5%)
Arthritis as primary illness (188) 70 (37.2%) 16 (8.5%) 60 (31.9%) 36 (19.2%) 4 (2.1%)    2 (1.1%)
3 Yes (343)a 109 (31.8%) 37 (10.8%) 120 (35%) 37 (10.8%) 39 (11.4%)   1 (0.29%)  
2 Yes (102)b 34 (33.3%) 9 (8.8%) 29 (28.4%) 11 (10.8%) 19 (18.6%)    
3 + 2 Yes (445) 143 (32.1%) 46 (10.3%) 149 (33.5%) 48 (10.8%) 58 (13%)    
Mental Health Condition (548) + PTSD (93) 184 (28.7%) 89 (13.9%) 195 (30.4%) 74 (11.5%) 97 (15.1%) 1 (0.16%) 1 (0.16%)  
Insomnia/Sleep Disorder (198) 63 (31.8%) 19 (9.6%) 65 (32.8%) 30 (15.2%) 19 (9.6%) 1 (0.51%)   1 (0.51%)
Gastrointestinal Disorder (62) + Crohn’s Disease (35) 34 (35.1%) 12 (12.4%) 26 (26.8%) 11 (11.3%) 14 (14.4%)    
Overall Medicinal Cannabis Cohort (2032) 632 (31.1%) 229 (11.3%) 617 (30.4%) 330 (16.2%) 212 (10.4%) 4 (0.20%) 2 (0.10%) 6 (0.30%)
  1. a3 “Yes” responses = 97% probability of migraine
  2. b2 “Yes” responses = 93% probability of migraine